• HOME
  • CONTACT US
Logo Logo Logo Logo Logo
  • Our Story
  • Our Team
    • Senior Management
    • Board of Directors
  • Technology
    • SUBA™ Itraconazole
    • Itraconazole Analogues
  • Programs
    • Prostate
    • Lung
    • Basal Cell Carcinoma
  • Partners
    • Mayne Pharma
    • PSI CRO
    • Weinberg Group
    • UConn
  • Investors & Media
    • Overview
    • News Releases
    • Events & Presentations
    • Stock Information
      • Interactive Chart
      • Historical Price Lookup
    • Financials & Filings
      • SEC Filings
      • Fundamentals
      • Annual Reports & Proxy Statements
    • Corporate Governance
      • Documents and Charters
      • Committee Composition
    • Investor Resources
  • Our Story
  • Our Team
    • Senior Management
    • Board of Directors
  • Technology
    • SUBA™ Itraconazole
    • Itraconazole Analogues
  • Programs
    • Prostate
    • Lung
    • Basal Cell Carcinoma
  • Partners
    • Mayne Pharma
    • PSI CRO
    • Weinberg Group
    • UConn
  • Investors & Media
    • Overview
    • News Releases
    • Events & Presentations
    • Stock Information
      • Interactive Chart
      • Historical Price Lookup
    • Financials & Filings
      • SEC Filings
      • Fundamentals
      • Annual Reports & Proxy Statements
    • Corporate Governance
      • Documents and Charters
      • Committee Composition
    • Investor Resources
Notice of Proposed Settlement of Stockholder Litigation. Click here for information.
Search:
 

SEC Filings

OTCQB: INTI
PRICE:
Stock Info
OTCQB: INTIOTCQB: HPPI
OTCQB: INTIOTCQB: HPPI
YearCalendar Year 2019Calendar Year 2018Calendar Year 2017Calendar Year 2016Calendar Year 2015Calendar Year 2014Calendar Year 2013Calendar Year 2012Calendar Year 2011Calendar Year 2010Calendar Year 2009Calendar Year 2008Calendar Year 2007Calendar Year 2006Calendar Year 2005Calendar Year 2004Calendar Year 2003Calendar Year 2002Calendar Year 2001Calendar Year 2000Calendar Year 1999Calendar Year 1998Calendar Year 1997
ViewAll FilingsAnnual FilingsQuarterly FilingsCurrent FilingsRegistration StatementsSection 16Mergers & AcquisitionsProxy & Information StatementsOther
FormDescriptionDateFormat
10-KAnnual report which provides a comprehensive overview of the company for the past yearApr 2, 2001Open Annual report which provides a comprehensive overview of the company for the past year in HTML.Open Annual report which provides a comprehensive overview of the company for the past year in DOC file.Open Annual report which provides a comprehensive overview of the company for the past year in PDF file.Open Annual report which provides a comprehensive overview of the company for the past year in XLS file.
Get Important News and Updates by Email
* Required Fields
Inhibitor-Therapeutics

900 West Platt Street
Suite#200
Tampa, Florida 33606-2173
Phone: 888-841-6811
Fax: 813-830-7489

Our Mission

Inhibitor Therapeutics, Inc. (“INHIBITOR”) is a pharmaceutical development company focused on developing and commercializing innovative therapies for patients with cancer and non-cancerous proliferation disorders. The company’s main focus is to advance its lead product, SUBA-Itraconazole a patented, oral formulation of the currently marketed, well-understood, anti-fungal drug, Itraconazole, for prostate and lung cancer.

  • Home
  • Our Team
  • Our Story
  • Technology
  • Programs
  • Partners
  • Investors & Media
  • Contact Us
  • Terms of Use and Privacy Policy

Copyright 2023 Inhibitor Therapeutics, Inc.